Predicting pancreatic cancer risk using diverse health data
Official title: Integrating epidemiologic, clinical, genomic and metabolomic profiles to predict pancreatic cancer risk in a multiethnic population
Funded at University of Southern California · NIH-11005721 · Data updated 2026-11-12
This study is looking to better predict who might be at risk for pancreatic cancer by combining different health information from a large and diverse group of people, so we can help identify those who need closer monitoring and early detection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | January 9, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $249,000 |
| NIH project number | 5R00CA256525-05 |
| Project ID | NIH-11005721 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from diverse racial and ethnic backgrounds, particularly those with a family history of pancreatic cancer or other risk factors.
✕Less likely to help
Patients who do not belong to the targeted multiethnic populations or those without any known risk factors for pancreatic cancer may not benefit from this research.
What this research studies
This research aims to improve the prediction of pancreatic cancer risk by integrating various health data, including epidemiologic, clinical, genomic, and metabolomic profiles from a diverse population. By utilizing the Multiethnic Cohort Study, which includes over 215,000 individuals from different racial and ethnic backgrounds, the study seeks to develop a more accurate model for identifying high-risk individuals. This approach considers a wide range of factors, including lifestyle, environmental influences, and genetic information, to enhance early detection of pancreatic cancer.
Why it matters
Potential benefit: If successful, this research could lead to better screening and early detection strategies for pancreatic cancer, particularly in high-risk populations.
How similar studies have gone: Previous research has shown promise in using integrated health data for cancer risk prediction, but this specific approach focusing on a multiethnic population is novel.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Huang, Brian — University of Southern California
- Study coordinator: Huang, Brian
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.